1. Home
  2. List
Reference Patent

Reference - List

  • 9 Hits
  • Search Condition : Filter (MeSH = Quinazolines / therapeutic use*)
Species Resource Title
Human and Animal Cells KP4(RCB1005) Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression.
Human and Animal Cells WEHI-3B(RCB2853) A secondary RET mutation in the activation loop conferring resistance to vandetanib.
Human and Animal Cells 9-15C(RCB2323) PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL.
Human and Animal Cells PC-9(RCB4455) Effect of metformin on residual cells after chemotherapy in a human lung adenocarcinoma cell line.
Human and Animal Cells HuH-7 Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma.
Human and Animal Cells LC-2/ad(RCB0440) , PC-14(RCB0446) , RERF-LC-AI(RCB0444) Peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based detection test for gefitinib-refractory T790M epidermal growth factor receptor mutation.
Human and Animal Cells LLC(RCB0558) Anti-invasive and metastatic activities of evodiamine.
Human and Animal Cells TKKK(RCB1907) , TGBC24TKB(RCB1196) , HuCCT1(RCB1960) Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma.
Human and Animal Cells MC3T3-E1(RCB1126) , ST2(RCB0224) Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292.